Bruce L. Moskovitz

3.3k total citations · 1 hit paper
35 papers, 2.3k citations indexed

About

Bruce L. Moskovitz is a scholar working on Infectious Diseases, Physiology and Epidemiology. According to data from OpenAlex, Bruce L. Moskovitz has authored 35 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 13 papers in Physiology and 11 papers in Epidemiology. Recurrent topics in Bruce L. Moskovitz's work include Antifungal resistance and susceptibility (14 papers), Pain Mechanisms and Treatments (9 papers) and Pain Management and Opioid Use (7 papers). Bruce L. Moskovitz is often cited by papers focused on Antifungal resistance and susceptibility (14 papers), Pain Mechanisms and Treatments (9 papers) and Pain Management and Opioid Use (7 papers). Bruce L. Moskovitz collaborates with scholars based in United States, Belgium and Israel. Bruce L. Moskovitz's co-authors include Carmelita U. Tuazon, Gretchen A. Cloud, William E. Dismukes, John R. Graybill, Michael S. Saag, Jack D. Sobel, Philip C. Johnson, Joseph A. Barone, Robert Bierman and John L. Colaizzi and has published in prestigious journals such as New England Journal of Medicine, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

Bruce L. Moskovitz

35 papers receiving 2.2k citations

Hit Papers

Treatment of Cryptococcal Meningitis Associated with the ... 1997 2026 2006 2016 1997 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome
    1997 540 citations Charles M. van der Horst, Michael S. Saag et al. New England Journal of Medicine profile →

Peers

Bruce L. Moskovitz
Jan Sjölin Sweden
Bertrand Gachot France
Hetty Waskin United States
Jerina Boelens Belgium
Alexander Imhof Switzerland
Susan Hadley United States
Robert Lupinacci United States
Gerald R. Donowitz United States
Koichiro Kudo Japan
James C. Hurley Australia
Jan Sjölin Sweden
Bruce L. Moskovitz
Citations per year, relative to Bruce L. Moskovitz Bruce L. Moskovitz (= 1×) peers Jan Sjölin

Countries citing papers authored by Bruce L. Moskovitz

Since Specialization
Citations

This map shows the geographic impact of Bruce L. Moskovitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce L. Moskovitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce L. Moskovitz more than expected).

Fields of papers citing papers by Bruce L. Moskovitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce L. Moskovitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce L. Moskovitz. The network helps show where Bruce L. Moskovitz may publish in the future.

Co-authorship network of co-authors of Bruce L. Moskovitz

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce L. Moskovitz. A scholar is included among the top collaborators of Bruce L. Moskovitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce L. Moskovitz. Bruce L. Moskovitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biondi, David M., Jim Xiang, Mila Etropolski, & Bruce L. Moskovitz. (2015). Tolerability and efficacy of tapentadol extended release in elderly patients ≥75 years of age with chronic osteoarthritis knee or low back pain. Journal of Opioid Management. 11(5). 393–403. 27 indexed citations
2.
Turk, Dennis C., Elizabeth J. Dansie, Hilary Wilson, Bruce L. Moskovitz, & Myoung Kim. (2014). Physicians' Beliefs and Likelihood of Prescribing Opioid Tamper-Resistant Formulations for Chronic Noncancer Pain Patients. Pain Medicine. 15(4). 625–636. 10 indexed citations
3.
Biondi, David M., Jim Xiang, Mila Etropolski, & Bruce L. Moskovitz. (2014). Evaluation of Blood Pressure and Heart Rate in Patients with Hypertension Who Received Tapentadol Extended Release for Chronic Pain: A Post Hoc, Pooled Data Analysis. Clinical Drug Investigation. 34(8). 565–576. 12 indexed citations
4.
5.
Wilson, Hilary, Elizabeth J. Dansie, Myoung Soo Kim, et al.. (2013). Clinicians' Attitudes and Beliefs About Opioids Survey (CAOS): Instrument Development and Results of a National Physician Survey. Journal of Pain. 14(6). 613–627. 43 indexed citations
6.
Vorsanger, G., et al.. (2011). Evaluation of study discontinuations with tapentadol immediate release and oxycodone immediate release in patients with low back or osteoarthritis pain. Journal of Opioid Management. 6(3). 169–179. 19 indexed citations
7.
8.
9.
Moskovitz, Bruce L., Carmela Benson, Aarti A. Patel, et al.. (2011). Analgesic treatment for moderate-to-severe acute pain in the United States: Patients’ perspectives in the Physicians Partnering Against Pain (P3) Survey. Journal of Opioid Management. 7(4). 277–286. 34 indexed citations
10.
Cloud, Gretchen A., Melinda Smedema, Ann M. LeMonte, et al.. (2000). Does Long-Term Itraconazole Prophylaxis Result in In Vitro Azole Resistance in Mucosal Candida albicans Isolates from Persons with Advanced Human Immunodeficiency Virus Infection?. Antimicrobial Agents and Chemotherapy. 44(6). 1585–1587. 63 indexed citations
11.
Stevens, David A., Howard J. Schwartz, Jeannette Y. Lee, et al.. (2000). A Randomized Trial of Itraconazole in Allergic Bronchopulmonary Aspergillosis. New England Journal of Medicine. 342(11). 756–762. 354 indexed citations
12.
McKinsey, David S., L. Joseph Wheat, Gretchen A. Cloud, et al.. (1999). Itraconazole Prophylaxis for Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection: Randomized, Placebo‐Controlled, Double‐Blind Study. Clinical Infectious Diseases. 28(5). 1049–1056. 106 indexed citations
13.
Saag, Michael S., Gretchen A. Cloud, John R. Graybill, et al.. (1999). A Comparison of Itraconazole Versus Fluconazole as Maintenance Therapy for AIDS‐Associated Cryptococcal Meningitis. Clinical Infectious Diseases. 28(2). 291–296. 157 indexed citations
14.
Gupta, Aditya K., et al.. (1999). Safety of itraconazole pulse therapy for onychomycosis. An update.. PubMed. Spec No. 17–25. 5 indexed citations
15.
Barone, Joseph A., Bruce L. Moskovitz, Joseph A. Guarnieri, et al.. (1998). Food Interaction and Steady‐State Pharmacokinetics of Itraconazole Oral Solution in Healthy Volunteers. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 18(2). 295–301. 66 indexed citations
16.
Graybill, John R., José A. Vázquez, Rabih O. Darouiche, et al.. (1998). Randomized Trial of Itraconazole Oral Solution for Oropharyngeal Candidiasis in HIV/AIDS Patients. The American Journal of Medicine. 104(1). 33–39. 76 indexed citations
17.
Potasman, Israel, et al.. (1997). Oral Fluconazole for <i>Candida</i> Urinary Tract Infection. Urologia Internationalis. 59(4). 252–256. 7 indexed citations
18.
Horst, Charles M. van der, Michael S. Saag, Gretchen A. Cloud, et al.. (1997). Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome. New England Journal of Medicine. 337(1). 15–21. 540 indexed citations breakdown →
19.
Murray, Patricia, et al.. (1997). Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients. Clinical Therapeutics. 19(3). 471–480. 46 indexed citations
20.
Moskovitz, Bruce L., et al.. (1988). Spiramycin therapy for cryptosporidial diarrhoea in immunocompromised. Journal of Antimicrobial Chemotherapy. 22(Supplement_B). 189–191. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan Sjölin Breakdown of academic impact, for papers by Bertrand Gachot Breakdown of academic impact, for papers by Hetty Waskin Breakdown of academic impact, for papers by Jerina Boelens Breakdown of academic impact, for papers by Alexander Imhof Breakdown of academic impact, for papers by Susan Hadley Breakdown of academic impact, for papers by Robert Lupinacci Breakdown of academic impact, for papers by Gerald R. Donowitz Breakdown of academic impact, for papers by Koichiro Kudo Breakdown of academic impact, for papers by James C. Hurley
Rankless by CCL
2026